Table 1.
Clinical and pathological status of 9 patients with nonfunctioning pancreatic neuroendcrine tumors
| No | Age (yr) | Sex | Size (mm) | Location | Number of tumor | EUS-FNA | Preoperative diagnosis | Surgical procedure | Lymphadenectomy |
Metastases |
Motoses | Ki67/MiB-1 (%) | WHO classification 2010 | TNM classification (ENET) | Prognosis (mo) | |
| Lymph node | Distant | |||||||||||||||
| 1 | 58 | F | 32 | Ph | 1 | No | Pancreatic tumor | DP | No | Direct Invasion | No | 0 | 0.2 | NET G1 | T2N1M0 | 59 alive |
| 2 | 73 | M | 22 | Ph | 1 | No | NET | PPPD | Regional | No | No | 1 | 5.8 | NET G2 | T2NOMO | 39 alive |
| 3 | 67 | F | 22 | Pb | 1 | Done | NET G1 | DP | Regional | Positive | No | 20 | 20 | NEC | T2N1M0 | 14 alive |
| 4 | 74 | F | 10 | Pb | 1 | No | Islet cell tumor | DP | No | No | No | 0 | 1.6 | NET G1 | T1N0M0 | 196 alive |
| 5 | 61 | M | 10 | Pb | 1 | No | Islet cell tumor | Partial resection | No | No | No | 0 | 0.1 | NET G1 | T1N0M0 | 135 alive |
| 6 | 51 | F | 9 | Ph | 1 | Done | NET G1 | PPPD | Regional | No | No | 0 | 1 | NET G1 | T1N0M0 | 64 alive |
| 7 | 47 | F | 6 | Ph | 4 | No | NET | SSPPD | Regional | No | No | 0 | 0.9 | NET G1 | T1N0M0 | 22 alive |
| 2.1 | Stage I | |||||||||||||||
| 1.2 | ||||||||||||||||
| 1.2 | ||||||||||||||||
| 8 | 75 | M | 6 | Ph | 1 | Done | NET G1 | SSPPD | Regional | No | No | 0 | < 1 | NET G1 | T1N0M0 | 20 alive |
| 9 | 56 | F | 5 | Ph | 1 | No | Cartinoid | Partial resection | No | No | No | 0 | 0.4 | NET G1 | T1N0M0 | 34 alive |
EUS-FNA: Endoscopic ultrasonography-fine needle aspiration; Ph: Head of pancreas; Pb: Body of pancreas; DP: Distal pancreatectomy; PPPD: Pylorus-preserving pancreatoduodenectomy; SSPPD: Subtotal stomach preserving pancreatoduodenectomy.